The following is a summary of some recent studies on COVID-19 and cancer presented at the annual meeting of the American Society of Clinical Oncology in Chicago.Patients with blood cancers have a significantly weaker antibody response to COVID-19 vaccines than patients with solid tumors, but they may still be well protected against severe illness from the virus, new data suggests.
The same team reported in a separate presentation on Saturday that data on the safety of COVID-19 vaccines for cancer patients"are reassuring." Survey responses from nearly 500 adults and children showed most experienced some after-effects, with pain at the injection site and fatigue most common. But severe reaction rates were low and interruptions to cancer treatment were uncommon .
"While the fraction of patients in the ASCO registry with breakthrough cases who were hospitalised remained fairly constant throughout 2021 , those with breakthrough cases occurring in the last month of 2021 and early 2022 had a lower hospitalisation rate , which is consistent with less severe cases of COVID-19 in patients infected with the Omicron variant," the researchers said in a summary of their presentation.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: thenewpaper - 🏆 7. / 63 Read more »